The app runs on the Apple Watch platform and collects biometric data while a user sleeps. Its machine learning algorithms use the data to create a sleep pattern profile, which allows the app to detect the onset of nightmares and use vibrotactile feedback to interrupt the nightmare without fully waking the user or interrupting their circadian sleep rhythm.
The “Breakthrough Status” designation, reserved for therapies for life-threatening conditions with no approved treatments, will expedite NightWare’s ongoing randomized clinical trials, then grant the app priority review for FDA approval.
More articles about AI:
Google Cloud, Informatica expand partnership to make massive datasets more AI-friendly
New AI platform matches patients to the DNA tests best for them
AI links city’s good mood days to risky behaviors
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.